Godrej Agrovet FY26: Revenue Tops ₹10,000 Cr, Profit Rises 10% Despite Costs

AGRICULTURE
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Godrej Agrovet FY26: Revenue Tops ₹10,000 Cr, Profit Rises 10% Despite Costs
Overview

Godrej Agrovet announced its FY26 financial results, achieving a milestone ₹10,000 crore in consolidated revenue for the first time. Annual consolidated profit grew 10.37% to ₹445.18 crore, helped by strong Q4 performance. The company recommended a 110% dividend, even as it managed one-time costs from asset impairment and new labour codes.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Godrej Agrovet Reports Record ₹10,000 Cr Revenue, 10.4% Profit Growth in FY26

Godrej Agrovet's consolidated annual revenue hit a record ₹10,232.68 crore in FY26, up 9.06% from the previous year. Annual consolidated profit increased 10.37% to ₹445.18 crore, driven by a strong surge in the fourth quarter.

Financial Highlights

Godrej Agrovet Ltd. announced its financial results for the year ended March 31, 2026. The company reported consolidated annual profit of ₹445.18 crore, a 10.37% increase year-over-year. The fourth quarter (Q4 FY26) saw profit surge 54.74% to ₹102.28 crore compared to ₹66.10 crore in Q4 FY25.
The Board of Directors recommended a final dividend of 110% (₹11.00 per share) for FY26. The company's statutory auditors issued an unmodified opinion on the financial results.

Revenue Milestone and Profit Drivers

Exceeding ₹10,000 crore in revenue marks a key milestone for Godrej Agrovet, reflecting its expanding market presence. The strong profit growth, especially in the fourth quarter, suggests improved operational performance and effective margin management amid market challenges.

Factors Impacting FY26 Results

New Labour Codes implemented in India from November 21, 2025, resulted in one-time costs for companies. Godrej Agrovet reported ₹30.44 crore in consolidated costs related to these codes for FY26. Additionally, the company recorded a ₹32.96 crore impairment provision on its investment in subsidiary Godrej Cattle Genetics Private Ltd. Earlier, in September 2025, Godrej Agrovet received an administrative warning from SEBI regarding delayed disclosures for its stake in subsidiary Astec Lifesciences.

Shareholder Returns and Future Outlook

The recommended 110% dividend offers a direct benefit to shareholders, signaling positive cash flow management. The company's efforts to integrate new labour codes and address asset impairments point to a focus on operational stability for future performance.

Key Risks to Watch

Consolidated borrowings rose to ₹1,468.43 crore by March 31, 2026, from ₹1,281.07 crore the previous year. Managing these debt levels and ensuring repayment capacity will be key. The ongoing effects of the new Labour Codes on operating expenses could impact profitability in future quarters. The impairment charge for Godrej Cattle Genetics highlights potential challenges within this subsidiary, requiring close oversight.

Industry Peers

Hatsun Agro Product Ltd., in the dairy sector, shows strong revenue growth. PI Industries Ltd., a leader in crop protection, is noted for its performance and innovation. LT Foods Ltd., focused on rice and staples, operates in the wider agri-product sector.

What Investors Will Track

Investors will monitor how Godrej Agrovet manages its rising debt and the continuing financial impact of the new Labour Codes. Performance of subsidiaries, especially Godrej Cattle Genetics after its asset impairment, will be closely watched. Key indicators for sustained growth will include future strategic initiatives, new product launches, and market share gains in core segments like animal feed and crop protection.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.